Johnson & Johnson (JNJ) Return on Sales (2009 - 2026)
Johnson & Johnson (JNJ) posted Return on Sales of 0.0% for Q2 2026, little changed sequentially from 0.0% in Q1 2026, and little changed YoY from 0.0% in Q2 2025.
Johnson & Johnson (JNJ) Return on Sales (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Return on Sales for 18 years, with the latest figure at 0.0% in Q2 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2023 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales was little changed at 0.0% in Q2 2026 per JNJ's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 0.0% in Q3 2023.
- A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2023 and 2024: Return on Sales rose 1 bps in 2023, then decreased 1 bps in 2024.
- Over 5 years, Return on Sales stood at 0.0% in 2022, then sank by 152 bps to 0.0% in 2023, then soared by 76 bps to 0.0% in 2024, then surged by 22106 bps to 0.0% in 2025, then grew by 5 bps to 0.0% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.77 Bn | 632.01 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 469.90 Bn | 463.33 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 377.04 Bn | 369.90 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 303.08 Bn | 295.39 Bn | 11.24 Bn | 0.00% |
| 5 | Astrazeneca | 257.74 Bn | 252.84 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 236.46 Bn | 222.47 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 181.81 Bn | 178.63 Bn | 6.22 Bn | -0.01% |
| 8 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 106.28 Bn | 102.11 Bn | 8.24 Bn | 0.00% |
| 10 | Sanofi | 55.01 Bn | 47.63 Bn | 10.79 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 0.00% |
| Mar 29, 2026 | 0.00% |
| Dec 28, 2025 | 0.00% |
| Sep 28, 2025 | 0.00% |
| Jun 29, 2025 | 0.00% |
| Mar 30, 2025 | 0.01% |
| Sep 29, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Oct 1, 2023 | 0.01% |
| Jul 2, 2023 | 0.00% |
| Apr 2, 2023 | 0.00% |
| Jan 1, 2023 | 0.00% |
| Oct 2, 2022 | 0.00% |
| Jul 3, 2022 | 0.00% |
| Apr 3, 2022 | 0.00% |
| Oct 3, 2021 | 0.00% |
| Jul 4, 2021 | 0.00% |
| Apr 4, 2021 | 0.00% |